Last updated: October 27, 2023
Sponsor: Montreal Heart Institute
Overall Status: Completed
Phase
N/A
Condition
Coronary Artery Disease
Chest Pain
Heart Disease
Treatment
Lifestyle intervention
Clinical Study ID
NCT03620539
ICM2017-2312
Ages 50-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- A history of angiographic coronary disease: ≥70% arterial diameter narrowing of atleast one major epicardial coronary artery and/or prior coronary revascularizationand/or documented prior acute coronary syndrome and/or perfusion defect duringexercise testing or pharmacological stimulation
- Stable medication doses (≥4 weeks) prior to enrolment
- Body mass index <35 kg/m2
Exclusion
Exclusion Criteria:
- Recent (<3 months) coronary artery disease-related hospitalization or change in anginapattern
- Unstable angina
- Ejection fraction <40% and/or clinical evidence of heart failure
- Significant valvular heart disease
- Uncontrolled hypertension (>180/110 mmHg)
Study Design
Total Participants: 61
Treatment Group(s): 1
Primary Treatment: Lifestyle intervention
Phase:
Study Start date:
December 04, 2018
Estimated Completion Date:
September 12, 2022
Study Description
Connect with a study center
Cardiovascular Prevention and Rehabilitation Centre of the Montreal Heart Institute
Montréal, Quebec H1T1N6
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.